R
68
2
OI
51
5
TGT
53
3
SIG
69
5
EIX
74
4
BK
65
2
OMC
66
4
AAP
36
3
PLD
58
3
TRIP
32
3
UAL
58
4
PFE
50
14
EA
38
2
SBUX
48
5
PRGO
46
2
ACN
13
2
EL
59
4
MMM
64
3
SPG
40
2
FDX
77
2
R
68
2
OI
51
5
TGT
53
3
SIG
69
5
EIX
74
4
BK
65
2
OMC
66
4
AAP
36
3
PLD
58
3
TRIP
32
3
UAL
58
4
PFE
50
14
EA
38
2
SBUX
48
5
PRGO
46
2
ACN
13
2
EL
59
4
MMM
64
3
SPG
40
2
FDX
77
2
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
78

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$41.01
Seasonality Move:
-1.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 11.8% based on the past 11 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $40.82. The Score for BBC is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • BBC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 11.8% based on the past 11 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Buy
78
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Buy

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
44.10
52-Week Low:
13.42

Prediction Charts

Market Cap:
0
Price in USD:
40.82
Volume:
21.9K
Beta:
1.30

Technical Analysis

SMA50:
40.28
SMA100:
35.84
SMA200:
28.42
52-Wk Change:
84.31%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 40.82 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-2 40.58 41.92 42.22 40.58
Feb-3 42.33 42.20 42.90 41.39
Feb-4 42.43 40.97 42.43 40.27
Feb-5 40.85 38.88 41.34 38.83
Feb-6 39.79 40.87 40.99 39.78
Feb-9 40.81 40.95 41.24 40.04
Feb-10 41.13 40.99 41.54 40.72
Feb-11 41.15 40.60 41.15 39.47
Feb-12 40.98 40.30 40.98 39.62
Feb-13 40.45 39.87 41.35 39.87
Feb-17 39.83 40.51 40.80 39.56
Feb-18 40.71 41.05 41.39 40.68
Feb-19 41.09 41.43 41.44 40.25
Feb-20 41.33 40.82 41.33 40.29

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.